Reading between the lines, and knowing that Michelle recently spent time in the States I would presume that talks are already underway with Pharmas. I also presume that a peer review has not been published as yet and predict a possible surge in the SP should it be a positive one. Then, there are the HIV mags such as POZ etc. An article in one or some of them may push the SP along a little. Thinking of emailing them with some info...All IMO
